China-based CRO HiRO, a portfolio company of Silver Dart Capital, acquires US-based CRO Courante Oncology, extending its global footprint.
The US FDA has granted Fast Track designation for its CRISPR-based therapy, EBT-101, a dual-cut CRISPR-based gene therapy for the treatment of human immunodeficiency virus type 1 (HIV-1).
Storefriendly, the Asia self-storage operator backed by investment giant Blackstone, introduced its two latest locations this past week at redeveloped properties.
Excision BioTherapeutics is testing a gene editing therapeutic “designed to cure HIV infections after a single intravenous infusion.”
Blackstone’s StoreFriendly’s JV completes $108M Kowloon self-storage buy
